ArticleDiabetology & metabolic syndrome2025
Association between stress hyperglycemia ratio and diabetic retinopathy progression and surgical prognosis: insights from NHANES 2005-2018 and clinical cohort study.
Article in Diabetology & metabolic syndrome, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05631054 (Establishment and Validation of a Risk Prediction Model for Long-term Low Vision After Vitrectomy in Proliferative Diabetic Retinopathy Patients), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Establishment and Validation of a Risk Prediction Model for Long-term Low Vision After Vitrectomy in Proliferative Diabetic Retinopathy Patients
Who cites it
1 citing paper in PubMed.
- Assessment of glycemic control among patients undergoing surgical treatment for advanced diabetic retinopathy in Saudi Arabia.International journal of retina and vitreous · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundDiabetic retinopathy (DR), a leading cause of vision loss in working-age adults, is strongly influenced by glycemic control. The stress hyperglycemia ratio (SHR), derived from admission glucose and HbA1c, has emerged as a potential predictor of adverse outcomes, yet its link to DR remains unclear. This study aimed to explore the association between SHR and DR using the NHANES database, as well as its impact on recurrent vitreous hemorrhage (RVH) and neovascular glaucoma (NVG) following pars plana vitrectomy (PPV) in patients with proliferative diabetic retinopathy (PDR).
methodsFirst, the association between SHR and DR was evaluated using multivariable logistic regression analysis based on NHANES database (2005-2018), including 4539 eligible diabetic patients, of whom 968 had DR. Second, 250 eyes from 201 PDR patients undergoing PPV were retrospectively analyzed and divided into two groups by median preoperative SHR. Risk factors for complications were identified using multivariable logistic regression, and paired analyses compared SHR levels at complication onset versus initial PPV surgery.
resultsIn the cross-sectional study based on the NHANES database, multivariate logistic regression revealed a significant positive association between SHR and DR risk after adjusting for all covariates (corrected OR = 1.65, 95% CI: 1.12-2.44; p = 0.014). In the retrospective cohort study, multivariable regression indicated that older age and higher fibrinogen levels were linked to increased postoperative complication risk (p < 0.01). Paired analyses demonstrated significantly higher SHR levels at complication onset compared to initial PPV surgery (p < 0.001).
conclusionSHR was significantly and positively correlated with the incidence of DR. Furthermore, in individuals with PDR, elevation of SHR was closely associated with the occurrence of postoperative complications, suggesting that SHR may be a valuable marker for postoperative adverse events. These results indicate that SHR provides a new clinical basis for the early warning of DR and risk assessment of postoperative complications.
trial registrationClinicaltrials.gov NCT05631054 Registered November 30, 2022 https//clinicaltrials.gov/study/NCT05631054.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.